
Surgical oncologist, art lover, curious researcher, world traveler, idealistic mother and woman.
Selected publications from PubMed
Feasibility and safety profile of high-dose oxaliplatin-based PIPAC (120mg/m2) in the treatment of advanced peritoneal metastatic disease: MINOS real-life multicenter study.
Zambrano DA, Lintis A, Kefleyesus A, Taibi A, Eveno C, Pocard M, De Meeus G, Quénet F, Kepenekian V, Hübner M, Glehen O, Sgarbura O
Eur J Surg Oncol. 2026 May;52(5):111731 doi: 10.1016/j.ejso.2026.111731.
Ten-year of French multicentric experience in the management of peritoneal mesothelioma with 924 patients.
Noiret B, Lenne X, Piessen G, Sgarbura O, Bruandet A, Kepenekian V, Eveno C
Eur J Surg Oncol. 2026 Apr;52(4):111492 doi: 10.1016/j.ejso.2026.111492.
Proposed strategy after complete LAMN (low-grade appendiceal mucinous neoplasm) resection by different RENAPE units: need for a new consensus?
Mouawad C, Taibi A, Sgarbura O, Djelil D, Marchal F, Sourrouille I, Goere D, Glehen O, Ferron G, Dumont F, Courvoisier Clement T, Brigand C, Amroun KL, Abboud K, Villeneuve L, Pocard M, RENAPE Group
Pleura Peritoneum. 2026 Mar;11(1):49-54 doi: 10.1515/pp-2025-0037.
The clinical benefit of a near complete cytoreduction in patients with colorectal peritoneal metastases: a propensity score matched study.
Cashin PH, Morris D, Esquivel J, Larsen SG, Takala H, Dumont F, Sourrouille I, Kepenekian V, Tuech JJ, Bereder JM, Ortega-Deballon P, Abboud K, Regimbeau JM, Sgarbura O, Glehen O, BIG-RENAPE
Eur J Surg Oncol. 2026 Mar;52(3):111437 doi: 10.1016/j.ejso.2026.111437.
Peritoneal Surface Oncology surgery: Reflections on key determinants of success for female surgeons in this challenging discipline.
Rau B, Bhatt A, Bijelic L, Sgarbura O, Goere D, Bakrin N, Eveno C, Cortes-Guiral D, Chia-Shulyn C, Flatmark K
Eur J Surg Oncol. 2026 Feb;52(2):110434 doi: 10.1016/j.ejso.2025.110434.
Help your network discover Dr. Olivia Sgarbura's clinical expertise.